Abstract: Disclosed are methods of inhibiting neovascularization in a subject by administering to the subject a pharmaceutical preparation of R?-Glu-Trp-R?.
Abstract: A pharmaceutical preparation for the therapy of immune deficiency conditions comprising an active principle--a peptide of the structure: H--L--Glu--L--Trp--OH and a pharmaceutically acceptable vehicle.
Type:
Grant
Filed:
June 7, 1995
Date of Patent:
September 29, 1998
Assignee:
Cytoven J.V.
Inventors:
Vyacheslav Grigorievich Morozov, Vladimir Khatskelevich Khavinson
Abstract: A pharmaceutical preparation for the therapy of immune deficiency conditions comprising an active principle--a peptide of the structure: H-L-Glu-L-Trp-OH and a pharmaceutically acceptable vehicle.
Type:
Grant
Filed:
June 7, 1995
Date of Patent:
June 16, 1998
Assignee:
Cytoven J.V.
Inventors:
Vyacheslav G. Morozov, Vladimir K. Khavinson
Abstract: A pharmaceutical preparation for the therapy of immune deficiency conditions comprising an active principle--a peptide of the structure: H-L-Glu-L-Trp-OH and a pharmaceutically acceptable vehicle.
Type:
Grant
Filed:
June 7, 1995
Date of Patent:
October 7, 1997
Assignee:
Cytoven J.V.
Inventors:
Vyacheslav G. Morozov, Vladimir K. Khavinson
Abstract: A pharmaceutical preparation for the therapy of immune deficiency conditions comprising an active principle--a peptide of the structure: H-L-Glu-L-Trp-OH and a pharmaceutically acceptable vehicle.
Type:
Grant
Filed:
November 10, 1994
Date of Patent:
July 23, 1996
Assignee:
Cytoven J.V.
Inventors:
Vyacheslav G. Morozov, Vladimir K. Khavinson